Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pKM2L-phSMAD7 (#RDB05888)

Promoter Bank clone, Human Smad7 promoter

Alternative name p1953-8F
Clone info. PCR amplified human Smad7 promoter sequence was inserted into a Renilla luciferase reporter vector pKM2L (RDB04026). This clone has genomic sequence (48,951,746 to 48,955,347nt of NC_000018.10) corresponding -3.3 kb to +270 bp (tanscription start site P1 is designated +1. Fig. 2 of Denissova, N.G. et al. Proc. Natl. Acad. Sci. USA 97: 6397-6402, 2000). Note that this clone does not contain any part of cDNA sequence of NM_005904.3, a representative sequence of human SMAD7. Alternatively, 48955347 to 48951747(NC_000018.10); relatively -4636 to -1035, where +1 corresponds to 1 nt of NM_005904.3 was cloned. (reference: Proc. Natl. Acad. Sci. U.S.A., 97, 6397-6402, 2000, PMID:10823886; J. Biol. Chem., 275, 29308-2917, 2000, PMID:10887185)
Comment PCR cloning, forward primer, 1953 F4: 5' gtgtgctccggcctctcattacag 3'; reverse primer, 1953 R4: 5' tcctcctccgagactctcctcgt 3' Known differences (at least): C insertion between 48,952,117 and 48,952,118nt. G to A substitution corresponding to 48,951,914nt of NC_000018.10. Entire sequence of promoter region has not been confirmed.
Vector backbone pKM2L (RDB04026) (Plasmid)
Size of vector backbone 4.2 kb
Selectable markers Kan^r
Gene/insert name Human Smad7 genomic DNA
Depositor|Developer DNA Bank, |
 

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
Additional terms and conditions:
The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 1. 本件リソースは学術研究機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。
MTAに書く付加的使用条件:
本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB05888 pKM2L-phSMAD7 DNA solution

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pKM2L-phSMAD7 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB05888).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB05888_A9Cfp1-1.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: M13_-40 ()
Sequence file: RDB05888_A9Cfa.seq check
>05888_05888_A9Cf_M13_-40_E01_05_ABI08.ab1
    1 AAGCAGTTCA AGCTTGCATG CCTGCAGGTC ATTTAAATAG GGATAACAGG GTAATGATTA
   61 AGATCTCGAG CTCTAAGCTT CACATATGCA TGCACTAGTG GCGTGTGCTC CGGCCTCTCA
  121 TTACAGAGCC TTAGCACTAC TGGCCAGATC TCCAAAAGAT TCTTCAGATT CTCCATTTAG
  181 CCAAGAAACT GAATTAGAAT TATGACCTCT ACTTTCTCTG CTTATTTAAG TCCTTTCTGT
  241 TGCTATGAAG CCTGGTCTGA CCACTCTCAA TAAGTGAAGA TCTTTTAGGG AGATCCAGAA
  301 CAGAGAGGGA ATGGGACCCT AGAGAGCGGA AACTTGCCCA GAAAATCTTA TAAACTCTGC
  361 CAAGTGCTCG CCTAACGTGG GGATTGCTGT TGGCCCTAGT TGCTTAACCA GTGAGCGGCA
  421 ACGCCCCAGC CTGGAATCAG GTTTTCTGAC CTCTAGTCTG GTACTCTTTC TAAGCCTTTC
  481 TAAGGTGAAA ATATGATACA TTTCCCAGAC ACCTTAAAAA TCCCATTTCT GGGCCGGGCG
  541 CTGTGGCTCA TGCCTGTTAT CCCACACTTT GGGAGGCTGA GGCGGGTGGA TCGCCTGAGC
  601 TCAGGAGTTC GAGACTAGCC TGGGCAACAC GGTGAAACCT TGTCTCTGCT AAAATACAAA
  661 AAAATTAGCG AGGTGTGGAG TGCACGTGTA GTTCCAGCTA CTAGGGAGGC TGAGGCAGGA
  721 GAATTGCTTG AACCCAGGAG GCGGAGGTTG CAGTGAGCTG AGATCATGCC ACTGCCCTCT
  781 AGGCTGGGTG ACAAAGCAAG GCTCCATCTC AAAAAAAAAA AAAAAAAAAA TCCCACTTCT
  841 GTCTCTTTCG TCTTCCCTTG CCTATCATGA TAGGCCTCCC AAAGTGCTGG GATTACACTC
  901 CTTCTCCATT CTCTCCTGTG CTTTCTCAGC TGCTGTCTTC ACAGGTTGCT TCTTAGAATG
  961 TTTTTTTTAA TACACACACA AGGTTTCAAT GCCCTTTTAT ACAAGCCATA TTTTAATTTA
 1021 CACAAAATTA TGATGTTATA CACTGCAGCT TATGGTGGCC TTTACACAGT AAATGTTCAG
 1081 ATTGCAGCTT CTGTCGTCAG TAGGATCTGC ACTGCTGCAT CTACTATCCT TCAAGGTCAT
1141 AAAGGTGTTT AAGGAATTCT TGCT
//
Primer: phRLR2primer ()
Sequence file: RDB05888_A9Cfb.seq check
>05888_05888_A9Cf_phRLR2primer_F01_06_ABI08.ab1
    1 ATTCTTTGTC TCGAAAGCCC AGTTTCTATT GGTCTCCTTA AACCTGTCTT GTAACCTTGA
   61 TACTTACCTG CCCAGTGCCT CACGACCAAC TTCTGCAGTA CCCGGGTGAA TTCTACGCGT
  121 CGACAGGCTC CTCCTCCGAG ACTCTCCTCG TCGCGCCCGG GAGCCTCCTT GTCCCCGGTC
  181 CGCCCTCTCC TGGCGCTCCG GTCCTTCTGC CGCCGCCAGG GGCTCGCCGC GCCGCACTCA
  241 GGGGCTCAGG GGCCGGGCGC TCGGCGGCTC GGCGCCGACG GACTGGCTCT GTCTCAGGCA
  301 GCTCTCTCCC GCGCGGCGAG CGGACCGAGC ACGGCGCCCG GCTGGCTCGG CTGGCGCGGC
  361 TCGGGGACAG GATCTTCCGT GCGCCGAGCA GCAAGCGAGT GTGCCCGGGG CTCACCGCCT
  421 CCCGCAAGGC CTCCCGCCCC CGCCCCCTTC CCTCCCCCTT CCTCCCCCTT CCCTCCCCCG
  481 CCCCCAGCCG CCGCAGCCGC CGCCGCCTCC TCCCCGCCCC CCCGCACCCC CCCTCCGGCC
  541 CTCTGCTCGG CTGGTTCCAC TGCGCAGTGG CGCGCCCGGC TCCGGCCTCG TCACGTGGCC
  601 GTCTAGACAC CCTGTCGCTT TAAAAAAAAA AAAAGCGATT GTGTTTCGCA AACAACAGAT
  661 CGGGTTTCTA AAAGCTATTT CTCCCCCCAA CCCCCCGCCA CCGCCACCCC CTCCCGGGTC
  721 TGTAGAGGGG GTACCGATGG AGGGGAGAGA GATAGGTGGG GGGCAGAGAA GCTCCCAGAA
  781 TGGATTGAGC CCCGGCCGGA GCCATGGAGA AATTGGGAAA AGCAGGAGCA CCGAGGCGGG
  841 CTTCGCCGCG AGTTTTGAGC TGAGCGAGCG GGTCGTGGCC CGATTTCGAC CGGCTGGGTT
  901 TCCGCGGTGC ATCTCGCGCG GGTCGGCTTA GCGCGCTCAT TCATGGATTA TGTTAAAGCC
  961 CTGCGGTGAT CCTTGCCCGC CCCGAGGCAG GGAGGAAGCG CTGATCCGGT AAGCTTACGG
1021 ACTGACTAGG CTGGAAGTGC CTTAGGACAT CG
//
Primer: pAxCALNLF1 ()
Sequence file: RDB05888_A9Cfc.seq check
>05888_05888_A9Cf_pAxCALNLF1_G01_07_ABI08.ab1
    1 TACAAATGTA TCTTATCATG TCTGCTCGAA GCGGCCGCTC TAGAATTACT GCTCGTTCTT
   61 CAGCACGCGC TCCACGAAGC TCTTGATGTA CTTACCCATT TCATCTGGAG CGTCCTCCTG
  121 GCTGAAGTGG AGGCCCTTCA CCTTCACGAA CTCGGTGTTA GGGAACTTCT TAGCTCCCTC
  181 GACAATAGCG TTGGAAAAGA ACCCAGGGTC GGACTCGATG AACATCTTAG GCAGATCGTC
  241 GCTGGCCCGA AGGTAGGCGT TGTAGTTGCG GACAATCTGG ACGACGTCGG GCTTGCCTCC
  301 CTTAACGAGA GGGATCTCGC GAGGCCAGGA GAGGGTAGGC CGTCTAACCT CGCCCTTCTC
  361 CTTGAATGGC TCCAGGTAGG CAGCGAACTC CTCAGGCTCC AGTTTCCGCA TGATCTTGCT
  421 TGGGAGCATG GTCTCGACGA AGAAGTTATT CTCAAGCACC ATTTTCTCGC CCTCTTCGCT
  481 CTTGATCAGG GCGATATCCT CCTCGATGTC AGGCCACTCG TCCCAGGACT CGATCACGTC
  541 CACGACACTC TCAGCATGGA CGATGGCCTT GATCTTGTCT TGGTGCTCGT AGGAGTAGTG
  601 AAAGGCCAGA CAAGCCCCCC AGTCGTGGCC CACAAAGATG ATTTTCTTTG GAAGGTTCAG
  661 CAGCTCGAAC CAAGCGGTGA GGTACTTGTA GTGATCCAGG AGGCGATATG AGCCATTCCC
  721 GCTCTTGCCG GACTTACCCA TTCCGATCAG ATCAGGGATG ATGCATCTAG CCACGGGCTC
  781 GATGTGAGGC ACGACGTGCC TCCACAGGTA GCTGGAGGCA GCGTTACCAT GCAGAAAAAT
  841 CACGGCGTTC TCGGCGTGCT TCTCGGAATC ATAGTAGTTG ATGAAGGAGT CCAGCACGTT
  901 CATTTGCTTG CAGCGAGCCC ACCACTGAGG CCCAGTGATC ATGCGTTTGC GTTGCTCGGG
  961 GGTCGTACAC CCTTGGAAGC CATGGTGGCT AGCCTATAGT GAGTCGTATT AAGTACTCTA
 1021 GCCTTTAAGA GCTGTAATTT GAACTGGGAG TGGACACCTG TGGAGAAGAA AGGCAAAGTG
 1081 GAATGTCAGT AAGAACCAAT AGGTGCCTAT CAGAACGGCA GAGTCCTTCT CTGTCTCGAT
1141 AGCCCCAGAT TTTCTAGTAT TG
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles